Events & Presentations

Ablynx organises webcasts for analysts and investors on the occasion of financial results publications and product specific news. In addition, the Company’s presentations at investor conferences are often webcasted and made available for the broader public.

Upcoming IR Events

J.P. Morgan 35th Annual Healthcare Conference 2017
9-13 January 2017 - San Francisco (CA), USA

Degroof Petercam's Annual Healthcare Conference 2017
31 January 2017 - Brussels, Belgium

Recent IR Presentations

Jefferies 2016 London Healthcare Conference
16 November 2016 - London, UK

Click here to replay the webcast

pdf version of the presentation

Webcast presentatie - vobarilizumab, a novel best-in-class anti-IL-6R drug candidate for the treatment of RA
20 oktober 2016

Click here to replay the webcast

pdf version of the presentation

Ablynx 2016 half year results and business update
25 August 2016 - webcast presentation at 4pm CET

Click here to replay the webcast

pdf version of the presentation

Jefferies 2016 Healthcare Conference
7-10 June 2016 - New York, USA - webcast presentation of 8 June 2016

Click here to replay the webcast

pdf version of the presentation

Upcoming Scientific Events

58th ASH Annual Meeting & Exposition
3-6 December 2016 - San Diego (CA), USA

Tumour Models - Increasing the Value of Preclinical & Translational Research
6-8 December 2016 - London, UK

Clinical Trial Disclosure & Data Transparency Conference
7-8 December 2016 - London, UK

Advances in Inflammatory Bowel Diseases
8-10 December 2016 - Orlando (FL), USA

Beltox Annual Meeting 2016
9 December 2016 - Leuven, Belgium

Therapeutic Drug Monitoring of Biologics: Progress in Chronic Inflammatory Diseases
9 December 2016 - Amsterdam, The Netherlands

Recent Scientific Presentations

Poster "Impact of caplacizumab treatment on mortality and major thromboembolic events in acquired TTP: Phase II TITAN study results" presented at the 21st European Hemathology Association Congress
9 June 2016 - Copenhagen, Denmark

pdf version of the presentation

Nanobodies as a Versatile Approach for Developing Next Generation Immunotherapies
26 January 2016 - Washington (DC), USA

pdf version of the presentation

Additional data from the TITAN trial with the anti-vWF Nanobody, caplacizumab, in the treatment of acquired TTP
24 June 2015 - Toronto, Canada

pdf version of the presentation

Shareholders' Clubs

Individual investors can meet with the Ablynx management team at Ablynx’s Quarterly Shareholders’ Clubs organised at Ablynx.

The next events in Dutch will take place on:

7 December 2016 at 5.45pm - fully booked
8 March 2017 at 5.45pm
24 May 2017 at 5.45pm
13 September 2017 at 5.45pm
6 December 2017 at 5.45pm

To attend an event, please register via email:, mentioning your name and preferred day.

Please click here to download the presentation of the most recent shareholders' club.